For research use only. Not for therapeutic Use.
Nitrosocimetidine(CAT: I033362) is a derivative of cimetidine and a nitrosated compound used in pharmacological and toxicological research. As a modified histamine H2 receptor antagonist, it helps investigate the impact of nitrosation on receptor binding and enzymatic interactions, particularly in gastric acid secretion studies. Additionally, Nitrosocimetidine is employed in exploring the potential toxicological effects of nitrosated compounds, contributing to research on chemical carcinogenesis and drug safety. With its high purity and stability, it is suitable for in vitro and in vivo studies, providing a robust tool for advancing research in gastroenterology and toxicology.
Catalog Number | I033362 |
CAS Number | 73785-40-7 |
Synonyms | Nitrosocimetidine; CCRIS 1952; CCRIS-1952; CCRIS1952 |
Molecular Formula | C10H15N7OS |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | Guanidine, 2-cyano-1-methyl-3-(2-(((5-methylimidazol-4-yl)methyl)thio)ethyl)-1-nitroso- |
InChI | InChI=1S/C10H15N7OS/c1-8-9(15-7-14-8)5-19-4-3-12-10(13-6-11)17(2)16-18/h7H,3-5H2,1-2H3,(H,12,13)(H,14,15) |
InChIKey | LFTUYYPQNCJQGN-UHFFFAOYSA-N |
SMILES | O=NN(C)/C(NCCSCC1=C(C)NC=N1)=NC#N |